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A subset of older people is at increased risk of hospitalization and dependency. Emerging evidence suggests that immu-
nosenescence reflected by an inverted CD4:8 ratio and cytomegalovirus (CMV) seropositivity plays an important role in 
the pathophysiology of functional decline. Nevertheless, the relation between CD4:8 ratio and functional outcome has 
rarely been investigated. Here, CD4:8 ratio and T-cell phenotypes of 235 community-dwelling persons aged ≥81.5 years 
in the BELFRAIL study and 25 younger persons (mean age 28.5 years) were analyzed using polychromatic flow cytom-
etry. In the elderly persons, 7.2% had an inverted CD4:8 ratio, which was associated with CMV seropositivity, less naive, 
and more late-differentiated CD4+ and CD8+ T cells. However, 32.8% had a CD4:8 ratio >5, a phenotype associated with 
a higher proportion of naive T cells and absent in young donors. In CMV seropositives, this subgroup had lower propor-
tions of late-differentiated CD4+ and CD8+ T cells and weaker anti-CMV immunoglobulin G reactivity. This novel naive 
T-cell-dominated phenotype was counterintuitively associated with a higher proportion of those with impaired physical 
functioning in the very elderly people infected with CMV. This underscores the notion that in very elderly people, not 
merely CMV infection but also the state of its accompanying immune dysregulation is of crucial importance with regard 
to physical impairment.
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OLDER persons show differences in both innate and adaptive immune measures with increasing age, gener-
ally interpreted in terms of declining immune competence. 
One of the most prominent changes is a profound remode-
ling of CD8+ and to a lesser extent CD4+ T-cell phenotypes 
characterized by an accumulation of late-differentiated 
effector memory and effector T cells potentially filling 
the “immunological space.” These changes are generally 
believed to be detrimental because they are associated with 
a decreased response to vaccination, higher incidence and 
severity of infectious diseases, and a low chronic inflamma-
tory condition associated with frailty (1–3).
The β-herpesvirus human cytomegalovirus (CMV) has a 
major role in the remodeling of the T-cell compartment (4). 
CMV infection is also part of the original “Immune Risk 
Profile (IRP).” The concept of the IRP has emerged in an 
attempt to find predictive blood markers of deteriorating 
immune function based on the findings of the Swedish 
OCTO and NONA immune longitudinal studies (5–9). The 
IRP was associated with an elevated 2-, 4-, and 6-year mor-
tality rate (10).
Essentially, the IRP could be defined using solely an 
inverted CD4:8 ratio as a surrogate marker, which was pre-
sent in about 15% of free-living 85-year olds, caused by an 
accumulation of late-stage CD8+ memory cells. However, 
longitudinal follow-up showed that by the time the surviv-
ing OCTO and NONA participants had become nonagenar-
ians and centenarians, individuals with an inverted CD4:8 
were no longer present, suggesting selection against people 
with this risk factor (11). This implies that different risk 
factors may become prevalent at even more advanced age or 
under different conditions in different populations.
Along these lines, in the community-dwelling “Leiden 
85+” population, we observed that a lower proportion of naive 
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CD8+ T cells, associated with a higher proportion of memory 
cells, predicted better survival from the age of 89 years over a 
8-year follow-up (12). We postulated that the reason for this 
could be that in such a population, exposure to novel patho-
gens would be minimal, so that there would be no advantage 
to possessing more naive cells; in contrast, more memory 
cells, mostly CMV reactive, would be beneficial for more 
efficient immunosurveillance or control of CMV under these 
circumstances. In general, this higher frequency of effector 
memory-type cells could be beneficial because sessile elderly 
individuals are more likely to be challenged by previously 
encountered agents, or persistent viruses like CMV and other 
herpesviruses, rather than by novel pathogens.
Emerging evidence suggests that this immune remod-
eling also plays an important role in the pathophysiology 
of functional decline in the elderly people, in which a 
decreased CD4:8 ratio was associated with poor function-
ing in elderly people (13–15).
Similarly, a limited number of studies, though conducted 
in selected populations, have demonstrated a relation-
ship between CMV infection and functional ability (16). 
Nonetheless, the identification of a subset of older people at 
increased risk of hospitalization, dependency, and a reduced 
life expectancy is important for recommending measures 
aimed at prevention and rehabilitation at the earliest possible 
time at the individual level and for planning adequate health 
policies at the societal level. This is crucial because the forth-
coming so-called “grey epidemic” will pose a major chal-
lenge to our health care systems with an increased demand 
for social and medical care and economical costs (17).
Therefore, our objective in the BELFRAIL study was to 
investigate the T-cell phenotype distribution in a larger and 
less highly selected age group, compared with the Leiden 
85+ study, of community-dwelling participants aged 80 and 
older and investigate their relationship with CMV infec-
tion and functional ability. We confirmed the presence of 
an IRP defined as an inverted CD4:8 ratio, at about half the 
frequency in these participants compared with the Swedish 
study (7% vs 15%). But strikingly, we found that a much 
higher proportion of the population had exceedingly high 
CD4:8 ratios and that this correlated with a weaker anti-
CMV immunoglobulin G (IgG) reactivity and higher pro-
portion of physically impaired elderly people when they 
were infected with CMV.
Methods
Study Design and Participants
Data were derived at the second data point of the 
BELFRAIL study, a representative ongoing cohort study 
of community-dwelling individuals over 80  years old in 
Belgium. All participants in the study gave informed con-
sent, and the Biomedical Ethics Committee of the Medical 
School of the Université Catholique de Louvain of Brussels 
approved the study. The study design, methods, recruitment 
of participants, and characteristics of the cohort were pre-
viously described in detail (18). Briefly, 29 general practi-
tioner centers included 567 patients aged 80 and older at 
baseline (November 2, 2008, and September 15, 2009). 
Only three exclusion criteria were used: those with known 
severe dementia (Mini-Mental State Examination [MMSE] 
<15), those in palliative care, and those with medical emer-
gencies. Eighteen months after baseline, T-cell subsets 
were measured for a study population of 235 participants 
(Supplementary Figure S1). This random subgroup with a 
mean age of 86.7 years had no significant difference with the 
total BELFRAIL population, except a slightly lower non-
cardiovascular comorbidity and Geriatric Depression Scale 
(GDS)-15 score (Supplementary Table S1). A control group 
of 25 younger participants, with a mean age of 28.5 years, 
was recruited among faculty members and students.
Flow cytometry analysis
Between March 19, 2011, and May 10, 2011, peripheral 
blood mononuclear cells were isolated and cryopreserved 
from 276 older patients and 25 younger participants from 
the control group (isolated between January 10, 2012, and 
January 17, 2012). After thawing, 41 donors were excluded 
due to low quality of peripheral blood mononuclear cells. 
Cryopreserved peripheral blood mononuclear cells were 
treated with human immunoglobulin, GAMUNEX (Bayer, 
Leverkusen, Germany), and ethidium monoazide (Invitrogen, 
Karlsruhe, Germany) to block Fc receptors and label nonviable 
cells. Peripheral blood mononuclear cells were then stained 
indirectly with anti-CCR7 primary antibody (R&D Systems, 
Wiesbaden-Nordenstadt, Germany) and Pacific Orange–
conjugated goat anti-mouse IgG (Invitrogen). After block-
ing with mouse serum (Chemicon/Millipore, Schwalbach, 
Germany), directly conjugated monoclonal antibodies, CD3-
Alexa Fluor 700, CD4-PerCP, CD8-allophycocyanin-H7, 
CD45-RA-V450, CD28-PE (BD Biosciences, Heidelberg, 
Germany), CD27-allophycocyanin (BioLegend, San Diego, 
CA), and CD57-FITC (Immunotools, Freiburg, Germany) 
were added. After 20 minutes of incubation on ice, cells 
were washed and analyzed immediately on an LSR II cytom-
eter with FACSDiva software (BD Biosciences). The BD 
FACSDiva software calculated the spectral overlap between 
all channels automatically after measuring negative and 
single-color controls. Data were analyzed using FlowJo 
Software (Tree Star, Portland, OR). For data analysis, eth-
idium monoazide–positive cells were excluded. In the viable 
gate, lymphocytes were gated in a forward light scatter versus 
side scatter dot blot according to their size and granularity. T 
cells within the lymphocyte gate were characterized according 
to surface expression of CD45RA, CCR7, CD27, and CD28 
based on a model suggested by Romero and coworkers (19) 
(Supplementary Figure S2). Flow cytometry staining and data 
analysis were performed on blinded samples. Parent popula-
tions with counts below 150 were excluded from the analysis. 
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T-cell subsets were expressed as proportions and T-cell differ-
entiation indexes were determined at the individual donor level 
by calculating the ratio of late-differentiated effector memory 
and effector subsets divided by the frequency of naive T cells 
for each person (12). Absolute T-cell numbers (count/L) were 
calculated by the formula: total lymphocyte count (cells/μL) 
× 1,000 × frequency of T-cell subset in decimal.
cMv igG Status
The CMV IgG serostatus was determined by means of a 
recombinant CMV IgG immunoblot (Mikrogen, Neuried, 
Germany) using six different epitopes (IE-1, p150, CM2, 
p65, gB1, and gB2). An individual was defined to be CMV 
IgG positive, if the reactivity was at least weakly positive 
(+) for p150 or other antigens compared with a control and 
according to the information of the manufacturer. Based on 
the scores, high reactivity (++ and +++) and very high reac-
tivity (+++) were defined.
Performance Measures
The clinical research associate successfully carried out 
performance testing on 223 participants of the study pop-
ulation between December 9, 2010, and August 30, 2011 
(Supplementary Figure S1).
Physical Performance
The activities of daily living (ADL) and short physical per-
formance battery (SPPB) were assessed as a proxy for the 
participant’s physical dependence and performance, respec-
tively. Physical limitations of daily living were assessed by 
asking the respondent to describe the degree of difficulty 
they had with six ADL: climbing stairs, walking 5 minutes 
outdoors without resting, getting up and sitting down in a 
chair, dressing and undressing oneself, using own or public 
transportation, and cutting one’s own toenails. The total score 
was calculated by summing the scores of all of the activities 
(range: 6–30). The lowest gender-adjusted quartiles of ≤18 
or ≤17 for men and women were used as cutoff, respectively. 
The SPPB consists of timed measurements of walking speed, 
rising from a chair, putting on and taking off a cardigan, and 
maintaining balance in a tandem stand. Categories of perfor-
mance were created for each set of performance measures to 
permit analyses that included those unable to perform a task. 
The summary performance scale, ranging from 0 to 14, has 
been used in several studies and has been shown to be a reli-
able and valid measure of physical functioning (20–22). The 
lowest gender-adjusted quartiles of ≤4 for men and women 
were used as cutoff to define a physical impairment.
Mental Performance
The MMSE score and GDS-15 were reported as a proxy 
for the participant’s cognitive functioning and suspected 
depression status, respectively. For the MMSE, a cutoff of 
24 points (range: 6–30) was used for mild to severe cogni-
tive impairment. The GDS-15 has been especially designed 
to screen for suspected depression in the elderly people (23). 
A  cutoff of five of more points was used for a depressed 
status.
comorbidity
Noncardiovascular comorbidities were defined as thyroid 
problems, anemia, asthma, chronic obstructive pulmonary 
disease, Parkinson’s disease, arthritis, osteoarthritis, docu-
mented osteoporosis, malignancy, and renal insufficiency. 
Cardiovascular comorbidities were defined as hyperten-
sion, diabetes mellitus, hyperlipidemia, a history of angina 
pectoris or myocardial infarction, known cardiomyopathy, 
a history of transient ischemic attack or cardiovascular acci-
dent, peripheral arterial disease, a history of decompensated 
heart failure, atrial fibrillation, valvular disease, or a history 
of edema of the lower extremities.
Statistical analyses
Continuous data are presented as the mean and standard devi-
ation (SD) or median and interquartile range (IQR). Categorical 
data are presented as numbers and frequencies. Comparisons 
between different categories of participants were performed 
using the chi-square test or Fisher exact test, if appropriate, and 
Student’s t test or Mann–Whitney U test for continuous data. 
The Kruskal–Wallis test and p for trend test were used to com-
pare continuous and categorical data between three or more 
groups, respectively. p < .05 was considered to be statistically 
significant. Dot plots are shown with median and IQR.
The relationship between physical and mental functioning 
(dependent variable) and CD4:8 ratio phenotypes (independ-
ent variable) was assessed with multivariate logistic regression 
analyses. For all of the analyses, robust estimates were used 
because the assumption of constant variance of the error was 
violated (24). Two consecutive adjusted models were used to 
assess the relationship with physical and mental impairment. 
In the first model, age categories and gender were included 
to correct for potential confounding; in the second model, 
analyzed batch, number of cardiovascular comorbidities, and 
number of noncardiovascular comorbidities were added.
The statistical analyses were performed using STATA 
11 (StataCorp, College Station, TX) and GraphPad prism 6 
(GraphPad Software, San Diego, CA).
Results
Demographics and t-cell Subset Distribution of the old 
and young Population With Regard to cMv Serostatus
The mean age of the 235 study participants was 
86.7  years, of whom 67.2% were women. One hundred 
and three (74%) were CMV seropositive. None of these 
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participants was free of pathology of one type or another. 
Nine percent were institutionalized and significantly fewer 
women were present in the CMV-seronegative older per-
sons, together with a trend toward a higher education level 
(Table 1). The control group, consisting of 25 young adults, 
had a mean age of 28.5 years, of whom 60% were women. 
Twelve percent were CMV seropositive; these individuals 
were significantly older compared with the seronegative 
individuals (Table 1).
In the aged population, CMV seropositivity was signifi-
cantly associated with a lower CD4:8 ratio (R). Both, in 
the aged and young population, a higher CD8+ and CD4+ 
T-cell differentiation index were significantly associated 
with CMV seropositivity (Supplementary Table S2). Also, 
higher proportions of late-differentiated effector memory 
(EM3, defined as CD45RA−CCR7−CD28−CD27−) and 
late-differentiated effector (E, defined as CD45+CCR7−C
D28−CD27−) CD4+ and CD8+ T cells were significantly 
associated with a CMV infection. No significant differ-
ences were found with respect to the proportion of naive 
(N, defined as CD45RA+CCR7+CD28+CD27+) T cells 
between the seropositive and seronegative individuals. 
Nonetheless, lower proportions of early differentiation 
markers CD27+ and CD28+ and higher proportions of 
late-differentiated CD57+ cells were seen in the CD4+ and 
CD8+ subsets in CMV-seropositive individuals.
All of the T-cell phenotypes and ratios were significantly 
different between the old and young groups.
Distribution of t-cell Differentiation Phenotypes based 
on cD4:8 Ratios (R) Relative to cMv infection
Seventeen elderly individuals (7.2%) and one younger 
individual had an R < 1, which was significantly associ-
ated with a latent CMV infection in the older population 
(Table  2). Seventy-seven individuals (32.8%), of whom 
62.3% were CMV seropositive, had an R > 5. This group 
showed no difference in terms of proportions or absolute 
numbers of CD4+ T cells but had a significantly lower 
median CD8+ T-cell content (5.49%; absolute numbers, 
Kruskal–Wallis: p < .001). The phenotype R > 5 was not 
observed in any of the younger individuals (R
max
: 3.23). 
The R > 5 group was characterized by a significantly high 
proportion or absolute number of naive T cells and a low 
proportion or absolute number of EM3 CD4+ and E CD4+ 
and CD8+ T cells (Table 2 and Supplementary Figure S3).
When stratifying for CMV serostatus as a confounder, 
both the R > 5 CMV-seropositive and CMV-seronegative 
groups had a significantly higher frequency of naive CD4+ 
and CD8+ T cells compared with the 1 < R < 5 or R < 1 
group (Figure 1). This difference was also observed when 
absolute cell numbers were analyzed (results not shown). 
Higher proportions of late-stage E CD4+ and CD8+ T cells 
were observed only in the seropositive R < 1 and 1 < R < 5 
group compared with the R > 5 group (Figure 2A). Similarly, 
the EM3 CD4+ T-cell frequency was significantly higher in 
the seropositive R > 5 group only (Supplementary Figure 
S4A). The proportions of EM3 CD8+ T cells did not differ 
significantly across the three groups, independent of CMV 
infection. These exact differences for the late-differentiated 
E and EM3 CD8+ and CD4+ T cells were also observed in 
terms of absolute numbers (results not shown). Significantly 
higher proportions of CD4+ and CD8+ T cells expressing 
the costimulatory molecules CD27 were seen in the seropos-
itive R > 5 group compared with the 1 < R < 5 or R < 1 sero-
positive group (Supplementary Figure S4B). Furthermore, 
a significantly higher number of CD27+CD4+ T cells was 
also seen in the seronegative R > 5 group. Figure 2B shows 
that a significantly lower proportions of the CD8+ and CD4+ 
T cells were late differentiated or potentially “senescent” 
(CD57+) in the seropositive R > 5 group compared with the 
1 < R < 5 and R < 1 group. This difference was also observed 
in terms of absolute numbers (results not shown).
Relationship between anti-cMv igG Reactivity and 
cD4:8 Ratio
A linear trend toward higher proportions of individuals 
with high anti-CMV IgG reactivity against five major viral 
proteins (pp65, IE-1, CM2, gB1, and gB2) with decreasing 
Table 1. Demographics of the Study and Control Population, Based on Their Cytomegalovirus (CMV) Serostatus
Old General (n = 235) CMV+ (n = 173) CMV− (n = 62) p Value
Age, mean ± SD 86.7 ± 3.8 86.8 ± 3.8 86.4 ± 3.9 .530
Women, n (%) 158 (67.2) 123 (71.1) 35 (56.5) .035
Higher education, n (%) 27 (11.5) 16 (9.3) 11 (17.7) .075
Body mass index, mean ± SD 21.7 ± 3.6 21 ± 3.38 22.4 ± 4.1 .090
Ever smoked, n (%) 64 (27.23) 43 (24.9) 21 (33.9) .171
Non-CV comorbidity, median 
(interquartile range [IQR])
1 (1–2) 1 (1–2) 1 (1–2) .200
CV comorbidity, median (IQR) 3 (2–4) 2 (2–3) 3 (2–4) .306
Institutionalized, n (%) 21 (8.94) 17 (9.83) 4 (6.45) .424
Young General (n = 25) CMV+ (n = 3) CMV− (n = 22) p Value
Age, mean ± SD 28.5 ± 6.1 37.8 ± 11.6 27.2 ± 0.9 .003
Women, n (%) 15 (60) 2 (66.7) 13 (59.1) 1
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CD4:8 ratio was shown (Figure 3). The high IgG reactivity 
against tegument protein pp65 and very high IgG reactivity 
against pp65, IE-1, and gB1 were significantly less frequent 
with increasing CD4:8 ratio.
impairment of Physical and Mental Performance 
in Patients With a R > 5 or R < 1, Relative to cMv 
Serostatus
This study population had a mean ADL score of 21.8 ± 5.9, 
a mean SPPB score of 7.06 ± 3.7, a median MMSE score of 
28 (IQR: 26-29), and a median GDS-15 score of 2 (IQR: 
1–3). In the R > 5 phenotype, a significant subgroup of 
36.1% had a low SPPB score compared with the 23% in 
the 1 < R < 5 group (Figure 4). Likewise, a low ADL score 
was present in 33.3% of those with an R > 5 compared with 
20.9% in the 1 < R < 5 group. After stratification for CMV 
infection, a significant impairment of ADL and SPPB was 
only observed in the R > 5 group of CMV-seropositive 
individuals but not in those who were CMV seronegative 
(Figure  4). In the CMV-seropositive R > 5 group, 38.6% 
and 36.4% had SPPB and ADL impairment compared with 
Table 2. CD4:8 Ratio Distribution in Older Persons
Variables R < 1 (n = 17, 7.2%) 1 > R < 5 (n = 141, 60%) R > 5 (n = 77, 32.8%) p Value
Age, mean ± SD 87.7 ± 3.4 86.8 ± 3.9 86.4 ± 3.7 .24
Women, n (%) 12 (70.6) 96 (68.1) 50 (65) .85
CMV IgG+, n (%) 15 (88.2) 110 (78) 48 (62.3) .016
CD4+/CD3, median (IQR) 64.3 (45–80.11) 45.3 (29.5–78) 53.7 (39–74.5) .24
 N/CD4 24.5 (10.9–37.8) 34.4 (24.3–46.2) 55.7 (40.3–64.9) <.001
 EM3/CD4 6.04 (2.9–8.7) 1.49 (0.24–5.3) 0.27 (0.04–1.04) <.001
 E/CD4 0.62 (0.19–4.6) 0.4 (0.03–1.51) 0.08 (0.01–0.44) .003
CD8+/CD3, median (IQR) 39.5 (24.8–46.1) 11.6 (7.2–18.3) 5.49 (3.58–8.15) <.001
 N/CD8 0.78 (0.44–2.58) 3.67 (1.6–8.4) 10.4 (4.9–22.3) <.001
 EM3/CD8 5.55 (2–16.4) 3.36 (1.8–8.79) 2.98 (1.34–8.7) .276
 E/CD8 50.4 (37.8–60.3) 30.7 (16–42.1) 14.8 (8.3–26.4) <.001
Note: CM = central memory; CMV = cytomegalovirus; E = effector; EM3 = effector memory 3; IgG = immunoglobulin G; N = naïve; R = CD4/CD8 ratio.
Figure 1. Expression dot plots (median and interquartile range) of naive (CD45RA+CCR7+CD27+CD28+) CD4+ (upper row) and CD8+ (lower row) T-cell 
subset between CD4:8 ratio phenotypes, relative to cytomegalovirus serostatus. p value from Kruskal–Wallis test to compare between three phenotypes.
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22.6% and 20.2% in the 1 < R < 5 group, respectively. In the 
CMV-seronegative high-ratio group, 32% and 28.6% had 
SPPB or ADL impairment compared with 24% and 23.3% 
in the 1 < R < 5 group. No significant differences were 
found with respect to GDS-15 or MMSE score between 
people with an R > 5 and the 1 < R < 5 group, regardless of 
CMV infection (Supplementary Figure S5). No significant 
differences for physical or mental impairment were found 
Figure  2. Expression dot plots (median and interquartile range) of late-stage effector (CD45RA+CCR7−CD27−CD28−) T cells (A) and late-differentiation 
marker CD57 (B), relative to cytomegalovirus serostatus. p value from Kruskal–Wallis test to compare between three phenotypes.
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Figure 3. Proportion of older cytomegalovirus (CMV)-seropositive individuals with a high (upper) or very high (lower) anti-CMV IgG reactivity against five 
major structural proteins, relative to CD4:8 ratio phenotypes. The CMV IgG serostatus was determined by means of a recombinant CMV IgG immunoblot using 
six different structural epitopes (IE-1, p150, CM2, p65, gB1, and gB2). Based on the scored level, very high reactivity (+++) and high reactivity (++ and +++) were 
defined (**p < .05, *p < .10—p for trend test).
Figure 4. Percentage of physical impairment according to their CD4:8 ratio phenotype and cytomegalovirus serostatus. (chi-square test, *p < .05), SPPB: short 
physical performance battery; ADL: activities of daily living.
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between the R < 1 group and the 1< R < 5 group (Figure 4 
and Supplementary Figure S5).
After correcting for age and gender, the probability of 
having a low SPPB or ADL score was 2.42- or 2.9-fold 
higher in the seropositive R > 5 group than in the seroposi-
tive R < 5 group, respectively (Table 3). These odds ratios 
remained significant after further correction for the batch 
number, number of cardiovascular comorbidities, and num-
ber of noncardiovascular comorbidities.
age-Specific Prevalence of R > 5 in the belgian 
Population
To estimate the age-specific prevalence of the different 
CD4:8 ratio phenotypes, the CD4:8 ratios of 235 elderly 
and 25 younger individuals of the BELFRAIL study were 
pooled with the identically measured CD4:8 ratios of 54 
donors (range: 20–81 years) from a clinical influenza 
vaccine trial in Antwerp, Belgium. The study design, 
methods, recruitment of participants, and characteris-
tics of this study population were previously described in 
detail by Derhovanessian and coworkers (25). The CD4:8 
ratio significantly increased with 10-year age categories 
(Kruskal–Wallis, p = .002) and the R > 5 phenotype was not 
prevalent before the age of 50 years (Figure 5). Eighteen 
individuals had a CD4:8 ratio above 10, with very low CD8 
(median: 3.46; IQR: 1.57–5.37) T-cell proportions com-
pared with CD4 T cells (median: 50.9; IQR: 37.1–71.8; 
Supplementary Figure S3 and Table 2).
Discussion
To the best of our knowledge, here we have defined for 
the first time a large naive T-cell-dominated subgroup of 
elderly people with a CD4:8 ratio >5, which we have shown 
to be associated with lower anti-CMV IgG reactivities and 
a higher proportion of those with physical impairment in 
CMV-seropositive individuals. This was not the case for 
cognitive function.
Prevalence of cD4:8 Ratio Spectrum in older Persons
With decreasing CD4:8 ratio, there was merely an 
increase in CD8+ T-cell proportion compared with no 
change in the CD4+ T cells. This is in line with the CD8+ 
T-cell accumulation in the 15% of people with an inverted 
Table 3. Odds Ratios of Multivariate Logistic Regression Analysis Between Physical Functioning and High CD4:8 Ratio Phenotype, Stratified 
for CMV Infection
Unadjusted Model Model 1 Model 2
OR (CI) C-stat p value OR (CI) C-stat p value OR (CI) C-stat p value
CMV+
 SPPB impairment 2.17 (1.03–4.57) 0.58 .042 2.42 (1.12–5.26) 0.71 .025 2.33 (1.05–5.18) 0.75 .038
  Age categories 2.41 (1.52–3.81) <.001 2.24 (1.37–3.66) .001
  Gender 0.68 (0.29–1.6) .374 0.8 (0.32–1.99) .632
  Batch 0.98 (0.91–1.06) .674
  Number of CV 1.05 (0.84–1.32) .638
  Number of non-CV 1.4 (1.05–1.88) .024
 ADL impairment 2.67 (1.27–5.8) 0.61 .013 2.9 (1.3–6.47) 0.69 .009 2.72 (1.2–6.18) 0.72 .016
  Age categories 2 (1.26–3.17) .003 1.89 (1.16–3.09) .011
  Gender 0.95 (0.4–2.24) .901 1.06 (0.42–2.66) .897
  Batch 0.98 (0.9–1.06) .633
  Number of CV 1.12 (0.89–1.4) .331
  Number of non-CV 1.26 (0.95–1.68) .112
CMV−
 SPPB impairment 1.36 (0.44–4.26) 0.54 .595 1.69 (0.48–5.88) 0.75 .412 1.41 (0.38–5.24) 0.78 .610
  Age categories 2.82 (1.16–6.84) .022 2.87 (1.18–6.98) .02
  Gender 1.48 (0.41–5.37) .555 1.83 (0.47–7.18) .386
  Batch 1.06 (0.93–1.2) .416
  Number of CV 1.37 (1.02–1.84) .04
  Number of non-CV 1.08 (0.62–1.9) .783
 ADL impairment 1.02 (0.33–3.18) 0.50 .970 1.22 (0.36–4.15) 0.74 .750 1.01 (0.29–3.5) 0.77 .984
  Age categories 2.68 (1.16–6.21) .022 2.69 (1.2–6.02) .016
  Gender 1.05 (0.3–3.73) .938 1.2 (0.31–4.64) .792
  Batch 1.05 (0.93–1.19) .416
  Number of CV 1.3 (0.94–1.78) .109
  Number of non-CV 1.05 (0.6–1.81) .876
Notes: ADL  =  activities of daily living; CI  =  confidence interval; CMV  =  cytomegalovirus; C-stat = C-statistics; CV  =  cardiovascular; OR  =  odds ratio; 
SPPB = short physical performance battery. Model 1: age categories and gender. Model 2: age categories, gender, batch, number of cardiovascular diseases, and 
number of noncardiovascular diseases.
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CD4:8 ratio in the OCTO/NONA studies (8). In the pre-
sent cohort, only 7.2% of the elderly people (and one 
younger individual) had an inverted CD4:8 ratio, which 
might be due to the slightly higher age of the BELFRAIL 
participants. Indeed, in the Leiden 85+ cohort, only 2% 
of individuals aged 89  years showed an CD4:8 ratio <1 
compared with 20% in those between 70 and 81 years of 
age (12).
We observed a group of almost 33% with a CD4:8 ratio 
>5, not represented at all in the younger individuals who 
had a maximum CD4:8 ratio of 3.23. Pooling the CD4:8 
ratios with the CD4:8 ratios from 54 donors from a trial 
in Antwerp gave us a rough idea of the age-specific preva-
lence of the R > 5 phenotype in the Belgian population. 
This showed that the R > 5 phenotype and CD:8 ratio sig-
nificantly increased with age (Figure 5 and Supplementary 
Table S2), rather than decreased, suggesting that the R > 
5 is a distinct phenotype for older persons after the age of 
50 years. Likewise, Strindhall and coworkers (11) showed 
that in surviving OCTO/NONA participants older than 
100  years, no inverted CD4:8 ratio had been recorded 
from the age of 85 on and found the average CD4:8 ratios 
to increase with age. This increase with age in CD4:8 
ratio was also observed in the Japanese population (26). 
Although this finding was not emphasized, the NONA 
study in fact recorded a distinct subgroup of individuals 
with a CD4:8 ratio between 4 and 11 (8). The finding of 
increasing prevalence of the high CD4:8 ratio phenotype 
should be confirmed in additional populations in other 
countries to understand whether this other extreme end of 
the CD4:8 ratio distribution becomes relevant in late life. 
Additionally, because our groups younger than 80  years 
consisted of only 25 and 54 donors from another commu-
nity-dwelling study, future studies in different age groups 
are needed to establish whether the high ratio phenotype is 
indeed absent in younger individuals and if so, at what age 
it emerges.
Despite the immunosuppressed status of those with 
CD4:8 ratios above 10, no differences whatsoever were 
found in terms of available patient characteristics (age, 
comorbidity patterns, CMV serostatus, anti-inflammatory 
medication, infectious antibiotics prescriptions, etc.). Of 
course, we cannot completely rule out the possibility of 
nondiagnosed diseases (such as subclinical cancer or HIV) 
or of nonregistered medication use by the general practi-
tioner. Nevertheless, our very heterogenic population is a 
representative sample of the general oldest old. The nature 
and cause of this immunosuppressed status is certainly an 
important topic for future research.
the Relation between cD4 and cD8 Remodeling, cMv 
Serostatus, and cD4:8 Ratio Phenotypes
CMV infection was present in the majority of the elderly 
people and clearly associated with a lower CD4:8 ratio 
and expansion of the late-differentiated CD8+ and CD4+ 
T-cell compartment in our community-dwelling very 
elderly people, as has been previously reported in other 
populations (4,27). We did not observe a difference in 
the proportion of naive CD8+ and CD4+ T cells between 
the CMV-seropositive and CMV-seronegative individu-
als, which is probably the result of age-related exhaus-
tion (12). Consistent with the recent study of Turner and 
coworkers (28), the accumulation of late-stage CD8+ and 
CD4+ T cells was also seen in the three CMV-seropositive 
young individuals, although to a lesser extent, as all ratios 
and T-cell subsets were significantly different between the 
young and old groups.
BELFRAIL participants in the R > 5 group had the 
highest proportion of naive CD8+ and CD4+ T cells, inde-
pendent of CMV serostatus. In the case of CD4+ cells, 
the proportion of naive cells was almost as high as in the 
younger participants. Unfortunately, there is no evidence 
on whether these naive T cells are of (preserved) thymic 
origin despite the advanced age or whether they are periph-
erally produced, which should be further clarified in the 
future to better understand this phenotype and the origin 
of these cells. A  large difference in the distribution of E 
T-cell differentiation subsets was noticed in the CMV-
seropositive CD4:8 ratio phenotypes compared with the 
CMV-seronegative participants (Figure  4). This indicates 
a lesser or almost-absent CMV-associated expansion of the 
late-differentiated CD8+ and CD4+ T-cell compartment in 
those with a high CD4:8 ratio compared with higher fre-
quencies of these cells in CMV-seropositive donors with 
lower CD4:8 ratios.
Figure  5. Crude prevalence of CD4:8 ratio spectrum with age. Pooled 
CD4:8 ratio data from BELFRAIL study and a Belgian community-dwelling 
clinical trial on influenza vaccination. The CD4:8 ratio significantly increased 
with 10-year age categories (Kruskal–Wallis, p = .002).
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Relation between cD4:8 Ratio and impaired Physical 
Functioning With Regard to cMv Serostatus
We showed that impaired physical dependency (assessed 
by ADL) and performance (SPPB) were significantly more 
frequent in those elderly people with a high CD4:8 ratio. 
After stratification and correcting for possible confound-
ers, we showed that only the CMV-seropositive individuals 
with a high CD4:8 ratio included a higher percentage of per-
sons with an impaired physical status. This contrasted with 
similar percentages over the CMV-seronegative CD4:8 ratio 
subgroups. This impairment may be related to their naive 
cell–dominated T-cell compartment, with fewer effector 
memory cells available for controlling CMV (eg, in case of 
reactivation or superinfection), leading to a stronger inflam-
matory response upon uncontrolled viral reactivations. This 
strong inflammatory response needed to suppress an episode 
of CMV reactivation may be more extensive than the inflam-
matory response necessary to prevent reactivation trough 
the CMV effector T-cell-mediated immunosurveillance. It 
has been shown that inflammation affects muscle mass and 
strength and subsequently physical functioning (29,30). 
Therefore, the more excessive inflammation needed to coun-
ter reactivation may explain why physical functioning is more 
affected in the group with high CD4:8 ratio. Confirming our 
hypothesis, we also showed that the R > 5 group had signifi-
cantly lower proportions of individuals with high to very high 
anti-CMV IgG reactivity or a weaker humoral immunosur-
veillance against certain major viral proteins.
At first sight, these results are in contrast to a study of 
immunity in people living in a Spanish nursing home. Moro-
Garcia and coworkers (13) showed that poorly functioning 
elders, having a low ADL score, had a decreased CD4:8 
ratio. However, the lower number and younger age of the 
Spanish individuals, and particularly the fact that they were 
institutionalized, could explain these differences. In fact, our 
data are quite in line with the results from a different Spanish 
study on community-dwelling participants (the OCTABAIX 
immune study), which showed that the subgroup with poor 
health status did not have a lower CD4:8 ratio in individuals 
aged 85 years (14). Together, these studies emphasize the 
importance of comparing different populations under differ-
ent conditions, rather than expecting to find a global “one-
pattern-fits-all” set of biomarkers for immunity, aging, and 
physical performance. It remains to be seen whether survival 
will also be associated with an abnormally high CD4:8 ratio 
in our study. Nevertheless, our findings here are in line with 
data from the community-dwelling Leiden 85+ study, show-
ing that a lower proportion of naive CD8+ T cells presages 
a survival advantage at 8-year follow-up from the baseline 
age of 89 years (12). An inverted CD4:8 ratio, a hallmark 
of the IRP predicting all-cause mortality in other studies 
(31), was not associated with physical dysfunction in CMV-
seropositive individuals. As the case may be, the small num-
ber of individuals with a R < 1 have efficiently adapted to 
repeating CMV immunosurveillance, with high anti-CMV 
IgG reactivity, and this retention of memory cells specific 
for previously encountered antigens may provide a survival 
advantage in this particular population. This survival effect 
could also have been reflected in our cohort as no associa-
tion was shown between CMV seropositivity or IgG titers 
and functional impairment in the BELFRAIL study at base-
line (16), which could be due to the heterogeneity in CMV 
immunosurveillance. Thus, dysbalanced immunity or the 
nature of immunosurveillance against CMV may be crucial 
for healthy ageing, at least in the very elderly people. The 
time of primary infection and the dynamics of the infection 
though may importantly determine the effects of CMV.
Although cognitive functioning and depression has 
been previously linked to CMV infection or immune sta-
tus (15,32), no associations whatsoever were found with 
cognitive functioning (MMSE) or suspected depression 
(GDS-15) in the present study. This could partly be due to 
the fact that patients were selected at baseline for having 
an MMSE > 15. Nevertheless, several patients exhibited 
mental decline between baseline and the clinical research 
associate visit at T1 (Figure 1). On the other hand, different 
methodologies for measuring physical and mental ability 
and decline can give rise to a great amount of variability. 
Thus, a more detailed and standardized approach is neces-
sary to confirm these relationships.
Strengths and Limitations
The main strength of the present study is the large 
sample of community-dwelling very elderly people and 
information on associated clinical variables on functional 
outcome, which has rarely been investigated. These data, 
together with the immune parameters established here, will 
be crucial for assessing important variables in health and 
mortality over the foreseen follow-up period. An impor-
tant limitation of this study is the low number of only three 
CMV-seropositive younger individuals and two seronega-
tive donors with an inverted ratio. However, the main thrust 
of this study remains the comparison of heterogeneous 
groups of elderly individuals with longitudinal follow-up, 
rather than contrasting old with young in a cross-sectional 
study. Furthermore, we do not know whether these late-dif-
ferentiated T cells are CMV-specific clones or when persons 
became infected with CMV. The final outcome and implica-
tions of the immune parameters and CMV status measured 
here will become apparent over the next few years. But more 
comprehensive studies incorporating inflammatory markers 
in accordance with the natural history of CMV infection in 
oldest old participants will increase our understanding of 
the biological and clinical relevance of this phenotype.
Conclusions
We studied a rarely investigated immune phenotype in 
the very elderly people, characterized by a CD4:8 ratio >5 
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and retention of a large naive T-cell compartment, which 
was associated with lower anti-CMV IgG reactivities and 
a higher proportion of physical impairment in participants 
infected with CMV. These data are consistent with the 
rather counterintuitive findings from the Leiden 85+ study, 
indicating that preservation of naive-phenotype cells is 
not associated with a survival advantage at advanced age. 
This suggests not only CMV infection, but also the nature 
of CMV immunosurveillance, is crucial in the association 
with functional impairment in the very elderly people.
Supplementary Material
Supplementary material can be found at: http://biomedgerontology.
oxfordjournals.org/
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